SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031247
Filing Date
2023-11-09
Accepted
2023-11-09 16:05:43
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arav20230930_10q.htm   iXBRL 10-Q 1012036
2 EXHIBIT 31.1 ex_568984.htm EX-31.1 12286
3 EXHIBIT 31.2 ex_568985.htm EX-31.2 12301
4 EXHIBIT 32.1 ex_568986.htm EX-32.1 5441
5 EXHIBIT 32.2 ex_568987.htm EX-32.2 5465
  Complete submission text file 0001437749-23-031247.txt   5240342

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20230930.xsd EX-101.SCH 49139
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20230930_cal.xml EX-101.CAL 33147
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230930_def.xml EX-101.DEF 318575
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230930_lab.xml EX-101.LAB 299415
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230930_pre.xml EX-101.PRE 344984
57 EXTRACTED XBRL INSTANCE DOCUMENT arav20230930_10q_htm.xml XML 803157
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 231392289
SIC: 2834 Pharmaceutical Preparations